特发性肺纤维化 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "特发性肺纤维化" in Chinese language version.

refsWebsite

Global rank Chinese rank

26doi.org

2^nd place

23^rd place

13worldcat.org

5^th place

12^th place

5web.archive.org

1^st place

2nih.gov

4^th place

5^th place

2fda.gov

447^th place

581^st place

1atsjournals.org

low place

1modernmedicine.com

low place

1esmo.org

low place

1medscape.com

719^th place

889^th place

atsjournals.org

du Bois, Roland M.; Weycker, Derek; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; Kartashov, Alex; Lancaster, Lisa; Noble, Paul W.; Raghu, Ganesh. Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011-08-15, 184 (4): 459–466. ISSN 1073-449X. doi:10.1164/rccm.201011-1790OC.

doi.org

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine. 2002-01-15, 165 (2): 277–304. ISSN 1073-449X. doi:10.1164/ajrccm.165.2.ats01.
Hutchinson, John; Fogarty, Andrew; Hubbard, Richard; McKeever, Tricia. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. European Respiratory Journal. 2015-05-14, 46 (3): 795–806. ISSN 0903-1936. doi:10.1183/09031936.00185114.
Raghu, Ganesh; Weycker, Derek; Edelsberg, John; Bradford, Williamson Z.; Oster, Gerry. Incidence and Prevalence of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2006-10, 174 (7): 810–816. ISSN 1073-449X. doi:10.1164/rccm.200602-163oc.
Adkins, Jessica; Collard, Harold. Idiopathic Pulmonary Fibrosis. Seminars in Respiratory and Critical Care Medicine. 2012-09-21, 33 (05): 433–439. ISSN 1069-3424. doi:10.1055/s-0032-1325154.
Ekström, Magnus; Gustafson, Torbjörn; Boman, Kurt; Nilsson, Kenneth; Tornling, Göran; Murgia, Nicola; Torén, Kjell. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ Open. 2014-01, 4 (1): e004018. ISSN 2044-6055. doi:10.1136/bmjopen-2013-004018.
Richeldi, Luca; Collard, Harold R; Jones, Mark G. Idiopathic pulmonary fibrosis. The Lancet. 2017-05, 389 (10082): 1941–1952. ISSN 0140-6736. doi:10.1016/s0140-6736(17)30866-8.
Pulkkinen, Ville; Bruce, Sara; Rintahaka, Johanna; Hodgson, Ulla; Laitinen, Tarja; Alenius, Harri; Kinnula, Vuokko L.; Myllarniemi, Marjukka; Matikainen, Sampsa. ELMOD2 , a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. The FASEB Journal. 2009-10-04, 24 (4): 1167–1177. ISSN 0892-6638. doi:10.1096/fj.09-138545.
吳常瑋; 張皓鈞; 陳天華; 黃信端; 劉家榮; 王鶴健. 特發性肺纖維化. 2018-10-01. doi:10.6314/jimt.201810_29(5).02 （中文（臺灣））.
du Bois, Roland M.; Weycker, Derek; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; Kartashov, Alex; Lancaster, Lisa; Noble, Paul W.; Raghu, Ganesh. Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011-08-15, 184 (4): 459–466. ISSN 1073-449X. doi:10.1164/rccm.201011-1790OC.
Editorial Board. Respiratory Medicine. 2012-12, 106: i. ISSN 0954-6111. doi:10.1016/s0954-6111(12)70007-0.
Collard, Harold R.; Richeldi, Luca; Kim, Dong Soon; Taniguchi, Hiroyuki; Tschoepe, Inga; Luisetti, Maurizio; Roman, Jesse; Tino, Gregory; Schlenker-Herceg, Rozsa. Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis. European Respiratory Journal. 2017-05, 49 (5): 1601339. ISSN 0903-1936. doi:10.1183/13993003.01339-2016.
Richeldi, Luca; Davies, Huw Richard H R; Spagnolo, Paolo; Luppi, Fabrizio. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews. 2003-07-21. ISSN 1465-1858. doi:10.1002/14651858.cd002880.
Rafii, Rokhsara; Juarez, Maya M.; Albertson, Timothy E.; Chan, Andrew L. A review of current and novel therapies for idiopathic pulmonary fibrosis. Journal of Thoracic Disease. 2013-02, 5 (1): 48–73. ISSN 2072-1439. PMC 3548009 . PMID 23372951. doi:10.3978/j.issn.2072-1439.2012.12.07.
Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis. New England Journal of Medicine. 2012-05-24, 366 (21): 1968–1977. ISSN 0028-4793. doi:10.1056/nejmoa1113354.

dx.doi.org

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine. 2002-01-15, 165 (2): 277–304. ISSN 1073-449X. doi:10.1164/ajrccm.165.2.ats01.
SIMI 2015. National Research and Development Institute for Industrial Ecology http://dx.doi.org/10.21698/simi2015. 2015-10-25. 缺少或|title=为空 (帮助)
Hutchinson, John; Fogarty, Andrew; Hubbard, Richard; McKeever, Tricia. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. European Respiratory Journal. 2015-05-14, 46 (3): 795–806. ISSN 0903-1936. doi:10.1183/09031936.00185114.
Raghu, Ganesh; Weycker, Derek; Edelsberg, John; Bradford, Williamson Z.; Oster, Gerry. Incidence and Prevalence of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2006-10, 174 (7): 810–816. ISSN 1073-449X. doi:10.1164/rccm.200602-163oc.
Adkins, Jessica; Collard, Harold. Idiopathic Pulmonary Fibrosis. Seminars in Respiratory and Critical Care Medicine. 2012-09-21, 33 (05): 433–439. ISSN 1069-3424. doi:10.1055/s-0032-1325154.
Ekström, Magnus; Gustafson, Torbjörn; Boman, Kurt; Nilsson, Kenneth; Tornling, Göran; Murgia, Nicola; Torén, Kjell. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ Open. 2014-01, 4 (1): e004018. ISSN 2044-6055. doi:10.1136/bmjopen-2013-004018.
Richeldi, Luca; Collard, Harold R; Jones, Mark G. Idiopathic pulmonary fibrosis. The Lancet. 2017-05, 389 (10082): 1941–1952. ISSN 0140-6736. doi:10.1016/s0140-6736(17)30866-8.
Pulkkinen, Ville; Bruce, Sara; Rintahaka, Johanna; Hodgson, Ulla; Laitinen, Tarja; Alenius, Harri; Kinnula, Vuokko L.; Myllarniemi, Marjukka; Matikainen, Sampsa. ELMOD2 , a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. The FASEB Journal. 2009-10-04, 24 (4): 1167–1177. ISSN 0892-6638. doi:10.1096/fj.09-138545.
Editorial Board. Respiratory Medicine. 2012-12, 106: i. ISSN 0954-6111. doi:10.1016/s0954-6111(12)70007-0.
Collard, Harold R.; Richeldi, Luca; Kim, Dong Soon; Taniguchi, Hiroyuki; Tschoepe, Inga; Luisetti, Maurizio; Roman, Jesse; Tino, Gregory; Schlenker-Herceg, Rozsa. Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis. European Respiratory Journal. 2017-05, 49 (5): 1601339. ISSN 0903-1936. doi:10.1183/13993003.01339-2016.
Richeldi, Luca; Davies, Huw Richard H R; Spagnolo, Paolo; Luppi, Fabrizio. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews. 2003-07-21. ISSN 1465-1858. doi:10.1002/14651858.cd002880.
Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis. New England Journal of Medicine. 2012-05-24, 366 (21): 1968–1977. ISSN 0028-4793. doi:10.1056/nejmoa1113354.

esmo.org

ESMO. European Medicines Agency Recommends Granting a Marketing Authorisation for Nintedanib. Available at: http://www.esmo.org/Oncology-News/European-Medicines-Agency-Recommends-Granting-a-Marketing-Authorisation-for-Nintedanib （页面存档备份，存于互联网档案馆）. Accessed in Jun 2015.

fda.gov

FDA. CY 2014 CDER Breakthrough Therapy Calendar Year Approvals. Available at:http://www.fda.gov/downloads/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/significantamendmentstothefdcact/fdasia/ucm380724.pdf （页面存档备份，存于互联网档案馆） Accessed in Jun 2015.
FDA. FDA approves Ofev to treat idiopathic pulmonary fibrosis. Available at:http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm418994.htm （页面存档备份，存于互联网档案馆） . Accessed in Jun 2015.

medscape.com

Medscape. Nintedanib (Ofev) Gets EMA Panel Backing for IPF. Available at:http://www.medscape.com/viewarticle/835390 （页面存档备份，存于互联网档案馆）. Accessed in Jun 2015.

modernmedicine.com

FDA grants priority review for IPF drug application. Available at: http://www.modernmedicine.com/modern-medicine/content/fda-grants-priority-review-ipf-drug-application?page=full （页面存档备份，存于互联网档案馆） . Accessed in Jun 2015.

nih.gov

ncbi.nlm.nih.gov

Rafii, Rokhsara; Juarez, Maya M.; Albertson, Timothy E.; Chan, Andrew L. A review of current and novel therapies for idiopathic pulmonary fibrosis. Journal of Thoracic Disease. 2013-02, 5 (1): 48–73. ISSN 2072-1439. PMC 3548009 . PMID 23372951. doi:10.3978/j.issn.2072-1439.2012.12.07.
King TE Jr1, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29;370(22):2083-92.PMID 24836312.

web.archive.org

FDA. CY 2014 CDER Breakthrough Therapy Calendar Year Approvals. Available at:http://www.fda.gov/downloads/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/significantamendmentstothefdcact/fdasia/ucm380724.pdf （页面存档备份，存于互联网档案馆） Accessed in Jun 2015.
FDA grants priority review for IPF drug application. Available at: http://www.modernmedicine.com/modern-medicine/content/fda-grants-priority-review-ipf-drug-application?page=full （页面存档备份，存于互联网档案馆） . Accessed in Jun 2015.
FDA. FDA approves Ofev to treat idiopathic pulmonary fibrosis. Available at:http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm418994.htm （页面存档备份，存于互联网档案馆） . Accessed in Jun 2015.
ESMO. European Medicines Agency Recommends Granting a Marketing Authorisation for Nintedanib. Available at: http://www.esmo.org/Oncology-News/European-Medicines-Agency-Recommends-Granting-a-Marketing-Authorisation-for-Nintedanib （页面存档备份，存于互联网档案馆）. Accessed in Jun 2015.
Medscape. Nintedanib (Ofev) Gets EMA Panel Backing for IPF. Available at:http://www.medscape.com/viewarticle/835390 （页面存档备份，存于互联网档案馆）. Accessed in Jun 2015.

worldcat.org

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine. 2002-01-15, 165 (2): 277–304. ISSN 1073-449X. doi:10.1164/ajrccm.165.2.ats01.
Hutchinson, John; Fogarty, Andrew; Hubbard, Richard; McKeever, Tricia. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. European Respiratory Journal. 2015-05-14, 46 (3): 795–806. ISSN 0903-1936. doi:10.1183/09031936.00185114.
Raghu, Ganesh; Weycker, Derek; Edelsberg, John; Bradford, Williamson Z.; Oster, Gerry. Incidence and Prevalence of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2006-10, 174 (7): 810–816. ISSN 1073-449X. doi:10.1164/rccm.200602-163oc.
Adkins, Jessica; Collard, Harold. Idiopathic Pulmonary Fibrosis. Seminars in Respiratory and Critical Care Medicine. 2012-09-21, 33 (05): 433–439. ISSN 1069-3424. doi:10.1055/s-0032-1325154.
Ekström, Magnus; Gustafson, Torbjörn; Boman, Kurt; Nilsson, Kenneth; Tornling, Göran; Murgia, Nicola; Torén, Kjell. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ Open. 2014-01, 4 (1): e004018. ISSN 2044-6055. doi:10.1136/bmjopen-2013-004018.
Richeldi, Luca; Collard, Harold R; Jones, Mark G. Idiopathic pulmonary fibrosis. The Lancet. 2017-05, 389 (10082): 1941–1952. ISSN 0140-6736. doi:10.1016/s0140-6736(17)30866-8.
Pulkkinen, Ville; Bruce, Sara; Rintahaka, Johanna; Hodgson, Ulla; Laitinen, Tarja; Alenius, Harri; Kinnula, Vuokko L.; Myllarniemi, Marjukka; Matikainen, Sampsa. ELMOD2 , a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. The FASEB Journal. 2009-10-04, 24 (4): 1167–1177. ISSN 0892-6638. doi:10.1096/fj.09-138545.
du Bois, Roland M.; Weycker, Derek; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; Kartashov, Alex; Lancaster, Lisa; Noble, Paul W.; Raghu, Ganesh. Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2011-08-15, 184 (4): 459–466. ISSN 1073-449X. doi:10.1164/rccm.201011-1790OC.
Editorial Board. Respiratory Medicine. 2012-12, 106: i. ISSN 0954-6111. doi:10.1016/s0954-6111(12)70007-0.
Collard, Harold R.; Richeldi, Luca; Kim, Dong Soon; Taniguchi, Hiroyuki; Tschoepe, Inga; Luisetti, Maurizio; Roman, Jesse; Tino, Gregory; Schlenker-Herceg, Rozsa. Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis. European Respiratory Journal. 2017-05, 49 (5): 1601339. ISSN 0903-1936. doi:10.1183/13993003.01339-2016.
Richeldi, Luca; Davies, Huw Richard H R; Spagnolo, Paolo; Luppi, Fabrizio. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews. 2003-07-21. ISSN 1465-1858. doi:10.1002/14651858.cd002880.
Rafii, Rokhsara; Juarez, Maya M.; Albertson, Timothy E.; Chan, Andrew L. A review of current and novel therapies for idiopathic pulmonary fibrosis. Journal of Thoracic Disease. 2013-02, 5 (1): 48–73. ISSN 2072-1439. PMC 3548009 . PMID 23372951. doi:10.3978/j.issn.2072-1439.2012.12.07.
Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis. New England Journal of Medicine. 2012-05-24, 366 (21): 1968–1977. ISSN 0028-4793. doi:10.1056/nejmoa1113354.